https://scholars.lib.ntu.edu.tw/handle/123456789/496675
標題: | Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis | 作者: | Zhong W.-B. CHIH-YUAN WANG TIEN-CHUN CHANG Lee W.-S. |
公開日期: | 2003 | 卷: | 144 | 期: | 9 | 起(迄)頁: | 3852-3859 | 來源出版物: | Endocrinology | 摘要: | Lovastatin has been used to treat hypercholesterolemia through blocking the mevalonate biosynthesis pathway. Inhibition of mevalonate synthesis may result in antiproliferation and cell apoptosis. The aim of the present study was to examine the apoptotic effect of lovastatin in human ARO cells and delineate its underlying molecular mechanism. Our results showed that lovastatin dose- and time-dependently induced apoptosis in ARO cells. Pretreatment with cycloheximide dose-dependently suppressed lovastatin-induced apoptosis, suggesting that de novo protein synthesis is required for lovastatin effect on the induction of apoptosis in ARO cells. Treatment of the cells with 50 μM lovastatin induced cytochrome c translocation from mitochondria to cytosol; increases in caspase-2, -3, and -9 activity; and poly (ADP-ribose) polymerase degradation in a time-dependent manner. However, administration of mevalonate or geranylgeraniol, but not farnesol, dose-dependently prevented lovastatin-induced poly (ADP-ribose) polymerase degradation and the occurrence of apoptosis, but treatment with geranylgeranyl transferase inhibitor, GGTI-298, which blocks the geranylgeranylation, induced an increase in the percentage of the apoptotic cells. These data suggest that geranylgeranylation is required for survival of the lovastatin-treated ARO cells. To support this notion, we demonstrate that lovastatin dose-dependently decreased the translocation of RhoA and Rac1, but not Ras, from cytosol to membrane fraction. Moreover, the lovastatin-induced translocation inhibitions in RhoA and Rac1 were prevented by mevalonate and geranylgeraniol but not farnesol. In conclusion, our data suggest that lovastatin induced apoptosis in ARO cells by inhibiting protein geranylgeranylation of the Rho family but not farnesylation of the Ras family. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-0041920695&doi=10.1210%2fen.2003-0098&partnerID=40&md5=0909eccbc11ccdbead43c4993dcf3f8f https://scholars.lib.ntu.edu.tw/handle/123456789/496675 |
ISSN: | 0013-7227 | DOI: | 10.1210/en.2003-0098 | SDG/關鍵字: | antineoplastic agent; caspase 2; caspase 3; caspase 9; cycloheximide; cytochrome c; farnesol; geranylgeraniol; ggti 298; mevalonic acid; mevinolin; poly(adenosine diphosphate ribose); protein synthesis inhibitor; Rac1 protein; RhoA guanine nucleotide binding protein; caspase; diterpene; hypocholesterolemic agent; mevinolin; protein serine threonine kinase; protein synthesis inhibitor; Rho guanine nucleotide binding protein; Rho kinase; Rho-associated kinase; RhoA guanine nucleotide binding protein; signal peptide; apoptosis; article; cancer cell; controlled study; cytosol; dose response; enzyme activity; gene translocation; human; human cell; mitochondrion; molecular dynamics; priority journal; protein degradation; protein synthesis inhibition; thyroid cancer; thyroid cell; cell culture; cell membrane; cell survival; drug effect; metabolism; protein processing; thyroid tumor; Anticholesteremic Agents; Apoptosis; Caspases; Cell Membrane; Cell Survival; Cytochrome c Group; Cytosol; Diterpenes; Humans; Intracellular Signaling Peptides and Proteins; Lovastatin; Protein Isoprenylation; Protein Synthesis Inhibitors; Protein-Serine-Threonine Kinases; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Thyroid Neoplasms; Tumor Cells, Cultured |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。